Medical News

RSS

New research: Significant number of HCV patients in the U.S. does not have health insurance coverage

New research has determined that patients in the U.S. with hepatitis C virus are twice as likely to not have health insurance coverage compared with those without the disease.

24 Feb 2011

New study: Multiple full-term pregnancies may have higher risk of 'triple-negative' breast cancer

Full-term pregnancy has long been associated with a reduced risk of breast cancer, but a new study finds that the more times a woman gives birth, the higher her risk of "triple-negative" breast cancer, a relatively uncommon but particularly aggressive subtype of the disease.

24 Feb 2011

SPIN program to help mothers produce sufficient breast milk for their premature infants

Approximately 50,000 premature babies weighing less than three pounds are born in the United States each year. These fragile newborns need the highest quality nutrition, which is why UC San Diego Health System developed the Supporting Premature Infant Nutrition program to help mothers produce sufficient breast milk for their premature infants.

24 Feb 2011

Study: Individuals with fatty liver more likely to develop type 2 diabetes

A recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism found that individuals with fatty liver were five times more likely to develop type 2 diabetes than those without fatty liver. This higher risk seemed to occur regardless of the patient's fasting insulin levels, which were used as a marker of insulin resistance.

24 Feb 2011

Simple home urine test can measure insulin in patients with diabetes

A simple home urine test has been developed which can measure if patients with Type 1 and Type 2 diabetes are producing their own insulin. The urine test, from Professor Andrew Hattersley's Exeter-based team at the Peninsula Medical School, replaces multiple blood tests in hospital and can be sent by post as it is stable for up to three days at room temperature.

24 Feb 2011

Thermo Fisher to sell Athena Diagnostics and Lancaster Labs businesses for $940 million

Thermo Fisher Scientific Inc., the world leader in serving science, announced today that it has signed definitive agreements to sell its Athena Diagnostics and Lancaster Laboratories businesses for a total of $940 million in cash.

From Thermo Fisher Scientific Inc. 24 Feb 2011

Michigan State University secures $7.9 million award to improve food security in Mozambique

Michigan State University has secured a $7.9 million award to improve agriculture and food security in Mozambique through increasing the African nation's agricultural productivity, creating economic opportunities and enhancing nutrition.

24 Feb 2011

Celgene, Elan enter settlement and license agreement for ABRAXANE

Elan Corporation plc and Celgene Corporation, today announced that Elan subsidiary Elan PharmaInternational Limited has entered into a settlement and license agreement with Celgene Corporation resolving the patent infringement litigation involving ABRAXANE.

24 Feb 2011

PolyMedix completes PMX-30063 Phase 1 exposure-escalation clinical study to treat Staph infections

PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat infectious diseases and acute cardiovascular disorders, today announced the successful completion of a Phase 1 exposure-escalation clinical study with its synthetic defensin-mimetic antibiotic, PMX-30063.

24 Feb 2011

FDA approves sBLA for CSL's Hizentra to treat PI

CSL Behring announced today that the U.S. Food and Drug Administration has approved a supplemental Biologics License Application to extend the shelf life of Hizentra, Immune Globulin Subcutaneous, 20% Liquid, from 24 months to 30 months.

24 Feb 2011

BioSante completes patient enrollment in LibiGel Phase III trial for treatment of FSD

BioSante Pharmaceuticals, Inc. today announced that enrollment of subjects in the first of two pivotal Phase III LibiGel safety and efficacy trials has been completed.

24 Feb 2011

Bruker to acquire Michrom Bioresources

Bruker today announced that it has signed an agreement to acquire Michrom Bioresources, Inc., a 20 year old, privately owned company based in Auburn, California. Michrom provides liquid chromatography instrumentation, accessories, and consumables for applications in the life science, chemical and applied markets.

24 Feb 2011

Multiplexed capillary isoelectric focusing increases efficiency in protein measurements

The Springer journal Analytical and Bioanalytical Chemistry (ABC) has chosen Oluwatosin O. Dada (34) as the recipient of its Best Paper Award 2010. Dada is the lead author of a paper in ABC on capillary isoelectric focusing. The award, accompanied by 1,000 euros, was created by Springer to help exceptional young scientists establish their research careers. The ABC Best Paper Award has been given since 2005.

24 Feb 2011

Lack of health insurance limits Hepatitis C patients' access to latest antiviral therapy

New research has determined that patients in the U.S. with hepatitis C virus (HCV) are twice as likely to not have health insurance coverage compared with those without the disease. In fact researchers found only a third of HCV infected Americans have access to antiviral therapy; the remaining are either uninsured or not candidates for therapy due to treatment contraindications. Details of this study are published in the March issue of Hepatology, a peer-reviewed journal of the American Association for the Study of Liver Diseases (AASLD).

24 Feb 2011

Willow launches Italian version breast health booklet

Willow Breast Cancer Support Canada (Willow) announces the publication of the Italian version of Be Breast Aware in conjunction with the 100th anniversary of International Women’s Day, on March 8th. The booklet:

24 Feb 2011

Erik Parens to speak on behavioral genetics at Presidential Commission meeting

Hastings Center Scholar Erik Parens, PhD, will speak about behavioral genetics to the Presidential Commission for the Study of Bioethical Issues on Monday, February 28. The meeting kicks off the Commission’s examination of the ethical and policy issues raised by genetics and neuroscience. Topics will include the use of genetics, neuroscience, and neuroimaging for testing, research, diagnosis, risk identification, and health promotion. Parens was invited to discuss what he considers the most pressing ethical and social issues that behavioral genetics research raises.

24 Feb 2011

PhRMA: 460 medicines in development for rare diseases

America's biopharmaceutical research companies are intensifying research into rare diseases, which often are among the most devastating to patients and complex for researchers. A record 460 medicines for rare diseases are in late stages of the pipeline, either in clinical trials or awaiting Food and Drug Administration (FDA) review, according to a report released today by the Pharmaceutical Research and Manufacturers of America (PhRMA).

24 Feb 2011

Foreign-born scientists and artists receive sixth annual Vilcek Prize for Biomedical Science

The Vilcek Foundation is pleased to announce the 2011 winners of its annual prizes honoring the contributions of foreign-born scientists and artists.

24 Feb 2011

Isis Pharma announces ISIS-CRPRx Phase 1 trial results in diseases with elevated CRP

Isis Pharmaceuticals, Inc. announced today the results from a Phase 1 clinical trial in which ISIS-CRPRx produced statistically significant reductions in C-reactive protein in the cohort of subjects in the study with elevated CRP.

24 Feb 2011

New guidelines recommend routine use of allergy tests to improve quality of care in children

The first guidelines for food allergy in children and young people issued by NICE, National Institute for health and Clinical Excellence, recommend routine use of allergy tests in NHS primary care and community settings to confirm suspected food allergy.

24 Feb 2011

Medical News

New research: Significant number of HCV patients in the U.S. does not have health insurance coverage

New study: Multiple full-term pregnancies may have higher risk of 'triple-negative' breast cancer

SPIN program to help mothers produce sufficient breast milk for their premature infants

Study: Individuals with fatty liver more likely to develop type 2 diabetes

Simple home urine test can measure insulin in patients with diabetes

Thermo Fisher to sell Athena Diagnostics and Lancaster Labs businesses for $940 million

Michigan State University secures $7.9 million award to improve food security in Mozambique

Celgene, Elan enter settlement and license agreement for ABRAXANE

PolyMedix completes PMX-30063 Phase 1 exposure-escalation clinical study to treat Staph infections

FDA approves sBLA for CSL's Hizentra to treat PI

BioSante completes patient enrollment in LibiGel Phase III trial for treatment of FSD

Bruker to acquire Michrom Bioresources

Multiplexed capillary isoelectric focusing increases efficiency in protein measurements

Lack of health insurance limits Hepatitis C patients' access to latest antiviral therapy

Willow launches Italian version breast health booklet

Erik Parens to speak on behavioral genetics at Presidential Commission meeting

PhRMA: 460 medicines in development for rare diseases

Foreign-born scientists and artists receive sixth annual Vilcek Prize for Biomedical Science

Isis Pharma announces ISIS-CRPRx Phase 1 trial results in diseases with elevated CRP

New guidelines recommend routine use of allergy tests to improve quality of care in children

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News